Alfa Laval announced a 1.1 BSEK (102 MEUR) contract to supply HVO pre-treatment equipment for Acelen's new Brazilian biorefinery, slated to begin operations in 2029 and produce over 17,230 barrels per day of SAF. As the company’s biggest order to date, it signals strong demand for biofuel infrastructure and could meaningfully boost Alfa Laval's long-term backlog and revenue visibility in a fast-growing sector.
The deal is the company’s largest ever and expands backlog with a high-value, long-duration revenue stream tied to SAF production, which can support valuation upside. Immediate price impact may be modest until revenue recognition and milestones approach in 2029.
Bullish over 6–12 months on backlog growth and revenue visibility from a high-value, long-cycle biofuels project.
Category: Industry News. The piece highlights a large, strategic contract in the biofuels infrastructure space, signaling demand growth for Alfa Laval’s HVO pre-treatment and related energy-transition solutions.